Skip to content

Author

P. Tembhare

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Utility of multiparametric flow cytometry in the diagnosis and staging of Classic Hodgkin lymphoma-Experience in real-world practice.

Published data on flow cytometric assessment of Classic Hodgkin lymphoma (CHL) are largely limited to lymph node biopsies, where histopathological and immunophenotypic findings are already available, thereby restricting its practical applicability. Real-world evidence demonstrating the additional diagnostic role of flo...

K. Balaji, S. Ghogale, N. Deshpande et al. · 0 citations
2027

Measurable Residual Disease.

P. Tembhare, N. Deshpande, S. Ghogale · 0 citations
Open access Sep 2026

Clinical Relevance of Genomics Defined WHO5 Subtypes of Pediatric B-ALL in the Context of Measurable Residual Disease-Directed Risk-Based Therapy.

PURPOSE WHO5 (2022) classification of B-lymphoblastic leukemia (B-ALL) incorporates several novel entities requiring high-throughput sequencing for their accurate characterization. The clinical relevance of this classification in the context of contemporary measurable residual disease (MRD)-directed therapy is unclear....

S. Rajpal, G. Chatterjee, P. Bhanshe et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.